UTP6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 9.26114740451567E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.99050004151746E-09 |
Normal-vs-Stage2 |
8.206600E-04 |
Normal-vs-Stage3 |
2.358200E-04 |
Normal-vs-Stage4 |
8.27399999958622E-07 |
Stage1-vs-Stage2 |
5.709800E-01 |
Stage1-vs-Stage3 |
5.006000E-01 |
Stage1-vs-Stage4 |
1.659370E-01 |
Stage2-vs-Stage3 |
9.808800E-01 |
Stage2-vs-Stage4 |
4.447800E-01 |
Stage3-vs-Stage4 |
4.709200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.02768962415712E-12 |
Normal-vs-AfricanAmerican |
1.41260000030563E-07 |
Normal-vs-Asian |
1.78211999999345E-05 |
Caucasian-vs-AfricanAmerican |
5.314000E-01 |
Caucasian-vs-Asian |
3.832400E-01 |
AfricanAmerican-vs-Asian |
2.613400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.60359528275944E-11 |
Normal-vs-Female |
3.28780003222562E-10 |
Male-vs-Female |
1.683620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.44449999999841E-05 |
Normal-vs-Extreme_Weight |
1.26910000286529E-08 |
Normal-vs-Obese |
4.38449999640156E-08 |
Normal-vs-Extreme_Obese |
5.644400E-02 |
Normal_Weight-vs-Extreme_Weight |
5.757400E-01 |
Normal_Weight-vs-Obese |
3.121000E-01 |
Normal_Weight-vs-Extreme_Obese |
9.381400E-01 |
Extreme_Weight-vs-Obese |
5.342600E-01 |
Extreme_Weight-vs-Extreme_Obese |
6.929400E-01 |
Obese-vs-Extreme_Obese |
5.229200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.68339999998091E-06 |
Normal-vs-Age(41-60Yrs) |
2.35955699423585E-12 |
Normal-vs-Age(61-80Yrs) |
5.93399995807431E-09 |
Normal-vs-Age(81-100Yrs) |
2.051200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.103660E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.082950E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.523700E-03 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.727700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.383700E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.554400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.63924429585904E-12 |
Normal-VS-Type2 PRCC |
9.848200E-04 |
Normal-VS-KIRP CIMP |
1.256230E-03 |
Normal-VS-Unclassified PRCC |
9.91190000000364E-05 |
Type1 PRCC-VS-Type2 PRCC |
1.61919999996929E-06 |
Type1 PRCC-VS-KIRP CIMP |
4.040000E-02 |
Type1 PRCC-VS-Unclassified PRCC |
3.345000E-01 |
Type2 PRCC-VS-KIRP CIMP |
4.642100E-04 |
Type2 PRCC-VS-Unclassified PRCC |
5.396400E-02 |
KIRP CIMP-VS-Unclassified PRCC |
5.855900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.91739999997076E-06 |
Normal-vs-N1 |
2.32399999999799E-05 |
Normal-vs-N2 |
9.988400E-01 |
N0-vs-N1 |
2.284100E-02 |
N0-vs-N2 |
1.137230E-01 |
N1-vs-N2 |
4.532000E-02 |
|
|